CATEGORY:

Men's Sexual Health & Erectile Dysfunction

DESCRIPTION:

F-1 is a compounded QuadMix-style intracavernosal injection formulated to support erectile function in men experiencing erectile dysfunction. This advanced formulation combines four active ingredients—papaverine, phentolamine, prostaglandin E1 (PGE-1), and atropine—that work together to promote increased blood flow to the erectile tissues and support the achievement and maintenance of an erection. Papaverine and phentolamine help relax smooth muscle and improve blood vessel dilation, while PGE-1 enhances blood flow directly within the corpus cavernosum. The addition of atropine provides an additional mechanism that may further support erectile response in certain patients who require more advanced therapy. This multi-agent approach allows healthcare providers to individualize treatment based on patient response and treatment goals. F-1 may be considered for men who have not achieved adequate results with oral ED medications or who require a more targeted treatment approach. Because the medication is injected directly into the penile tissue, it provides localized action and rapid onset compared to many oral therapies. Treatment should always be prescribed and monitored by a qualified healthcare provider. Proper dosing, administration training, and ongoing follow-up are essential to maximize effectiveness while minimizing potential side effects.

CATEGORY:

Men's Sexual Health & Erectile Dysfunction

DESCRIPTION:

F-1 is a compounded QuadMix-style intracavernosal injection formulated to support erectile function in men experiencing erectile dysfunction. This advanced formulation combines four active ingredients—papaverine, phentolamine, prostaglandin E1 (PGE-1), and atropine—that work together to promote increased blood flow to the erectile tissues and support the achievement and maintenance of an erection. Papaverine and phentolamine help relax smooth muscle and improve blood vessel dilation, while PGE-1 enhances blood flow directly within the corpus cavernosum. The addition of atropine provides an additional mechanism that may further support erectile response in certain patients who require more advanced therapy. This multi-agent approach allows healthcare providers to individualize treatment based on patient response and treatment goals. F-1 may be considered for men who have not achieved adequate results with oral ED medications or who require a more targeted treatment approach. Because the medication is injected directly into the penile tissue, it provides localized action and rapid onset compared to many oral therapies. Treatment should always be prescribed and monitored by a qualified healthcare provider. Proper dosing, administration training, and ongoing follow-up are essential to maximize effectiveness while minimizing potential side effects.